| 1 |
LU2208649280 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD |
+17,15 % |
+22,47 % |
0,73 |
| 2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
+17,51 % |
+22,17 % |
0,70 |
| 3 |
LU0258985083 |
Pictet - Biotech - Z USD |
+21,10 % |
+27,52 % |
0,69 |
| 4 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+17,21 % |
+22,22 % |
0,69 |
| 5 |
LU1269736911 |
Candriam Equities L Biotechnology, R - Capitalisation |
+16,85 % |
+21,86 % |
0,68 |
|
|
| 42 |
CH0113817123 |
Bellevue Biotech DT CHF |
+9,37 % |
+20,85 % |
0,35 |
|
|
| 85 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-6,79 % |
+14,23 % |
-0,62 |
| 86 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-7,44 % |
+14,23 % |
-0,66 |
| 87 |
LU2719280096 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating |
-7,77 % |
+14,58 % |
-0,67 |
| 88 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-7,88 % |
+14,58 % |
-0,68 |
| 89 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-8,53 % |
+14,58 % |
-0,72 |